3,0
5 mar 2026
Dipendente attuale, più di 3 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Improvement is happening, but it is very slow
Svantaggi
Company bought too many other companies at once trying to change systems, while combining several companies led to a lot of change and a hefty number of staff members to leave. We have lost most of leadership and a good amount of management and sales. I would estimate less than 50% of the team is from actual BioPlus (pre merger). Teams were VERY micromanaged, but new leadership seems to be relaxing the reigns and it's getting better. Commissions are essentially capped (they say it isn't but month to month, you cannot change it more than a few hundred bucks) This used to be somewhere you could work hard and earn money, now you work hard and make the same.